Health
As cancer rates soar in younger people, experts seek answers
From LifeSiteNews
By John-Michael Dumais, The Defender
Two recent reports by the American Cancer Society reveal alarming increases in numerous cancers among millennials and Gen Z in the U.S. While mainstream medical experts debate causes, some doctors told The Defender mRNA vaccines may be to blame for the recent emergence of aggressive cancers that often don’t respond to conventional treatments.
Cancer rates among younger generations are rising at an alarming pace, with medical professionals reporting unprecedented increases in aggressive cancers over the past few years.
A study published in the August edition of The Lancet Public Health revealed that through 2019, the incidence rates for 17 of 34 cancer types were increasing in progressively younger people in the U.S., ABC News reported on July 31.
Lead author Ahmedin Jemal, DVM, Ph.D., from the American Cancer Society (ACS) told The Washington Post that if current trends in cancer and mortality rates among Gen X and millennials continue, it “may halt or even reverse the progress that we have made in reducing cancer mortality over the past several decades.”
More recent data from the ACS’ “Cancer statistics, 2024” report — with data on cancer incidence through 2020 and mortality through 2021 — showed the trend continuing.
As of 2021, among adults under 50, colorectal cancer has become the leading cause of cancer death in men and the second-leading cause in women, despite ranking fourth for both sexes in the late 1990s.
Some researchers point to lifestyle, poverty and environmental factors as potential causes for the uptick in cancers, while others suggest the COVID-19 mRNA vaccines may be to blame for the rise in “turbo cancers.”
Meanwhile, Pfizer in December 2023 spent $43 billion for Seagan, a “cancer care” biotech company with only $2.2 billion in sales. Seagan’s already-approved drugs include those for bladder cancer, cervical cancer, breast cancer and Hodgkin lymphoma.
The acquisition expands Pfizer’s oncology portfolio to 25 approved drugs, which, by the second quarter of this year, helped the company recover from last year’s drop in COVID-19 vaccine sales when its stock lost half its value.
The cancer trend has also caught the attention of health organizations worldwide, including the World Health Organization, which in February predicted a 77% rise in new cancer cases — from 20 million cases in 2022 to over 35 million cases by 2050.
Which cancers are on the rise?
The Lancet study revealed disturbing trends in cancer rates for people born between 1920 and 1990, finding that through 2019, incidence rates for 17 of 34 cancer types analyzed were increasing in progressively younger birth cohorts.
For some cancers, the incidence rate was approximately 1 to 3 times higher in the 1990 birth cohort (people in their late 20s at the time of the study) compared to the 1955 birth cohort (people in their mid-60s at the time of the study).
Particularly concerning were the increases in cancers of the small intestine (256% higher), kidney and renal pelvis (192% higher), and pancreas in both males and females (161% higher). For women, liver and intrahepatic bile duct cancer rates also saw a significant uptick (105% higher).
In younger cohorts, cancer incidence also increased for estrogen receptor-positive breast cancer, uterine corpus (endometrial) cancer, colorectal cancer, non-cardia gastric (stomach) cancer, gallbladder and other biliary cancer, ovarian cancer, and testicular cancer, anal cancer and Kaposi sarcoma in males.
For those around 30 years old, cancer rates increased an average of 12% across all cancer types.
The study also noted that mortality rates mirrored incidence trends for several cancers, including liver cancer in females, uterine corpus, gallbladder and other biliary, testicular and colorectal cancers. This suggests that the increase in incidence is substantial enough to outweigh improvements in cancer survival rates.
The findings from the ACS’ cancer statistics report, which contains data through 2021, provide additional context to the rising cancer rates in younger generations, particularly for colorectal cancer in both sexes and breast, cervical, uterine and liver cancers in women.
The Ethical Skeptic, a well-regarded statistician on the social platform X, posted more recent cancer mortality data. The following graph, based on the Centers for Disease Control and Prevention’s WONDER online databases, shows excess mortality from malignant neoplasms (spreading tumors) “elevated 29% and still rising” for ages 0-54 through week 22 of 2024:

More recent ‘turbo cancers’
Dr. William Makis, a Canadian board-certified nuclear medicine radiologist and oncologist, reported in an interview on the “America Out Loud PULSE” podcast on July 6 that he has seen “just an explosion of extremely aggressive cancers in very young individuals” since the COVID-19 pandemic began.
Cancers Makis identified that are particularly affecting younger populations include breast cancer, colon cancer, bile duct cancer, pancreatic cancer, leukemia and lymphoma.
Makis emphasized that these cancers are presenting at advanced stages (3 or 4), are behaving “very aggressively” and are often resistant to conventional treatments. He referred to these as “turbo cancers” due to their rapid growth and spread.
Emmy Award winning FOX 4 Morning Reporter Matt Stewart announces he has Cancer – His Wife has also developed Cancer – 💔
“Friends, I have some devastating news to share with all of you. I have been feeling a little off mentally lately – dizzy, nauseous, a little double vision.… pic.twitter.com/NaiVzj8qN1
— “Sudden And Unexpected” (@toobaffled) July 28, 2024
Dr. Angus Dalgleish, a renowned oncologist and professor at St. George’s, University of London, has reported rapidly progressing cancers in patients receiving COVID-19 mRNA booster shots, although he did not specify the ages affected.
In particular, melanoma patients who had been in remission in his practice experienced sudden relapses. Cancer doctors around the world told him him about rapidly accelerating cancers, including lymphomas, leukemia, kidney and colorectal cancer and “multiple metastatic spread” of cancers throughout the body.
A Japanese study published in April in the journal Cureus reported post-COVID-19-vaccination increases in mortality for most age groups, including those under 50 years old. Cancers with the highest excess mortality rates included ovarian cancer, leukemia, prostate cancer, lip/oral/pharyngeal cancer and pancreatic cancer.

We do not have the data to point to
Mainstream medical experts have proposed several theories to explain the rising cancer rates among younger generations.
In the Lancet paper, the authors attribute the increase in cancers in younger people to higher exposure to carcinogens early in life, obesity, unhealthy diet, environmental chemicals, changes in reproductive patterns and alcohol-related behaviors.
In its “Cancer statistics, 2024” report, the ACS pointed to several additional potential culprits, including poverty-related factors such as inadequate health insurance and lack of access to screening and high-quality healthcare, and to structural racism-related factors, including mortgage lending bias and neighborhood-level redlining.
Dr. William Dahut, a medical oncologist and ACS chief scientific officer, told ABC News that finding a single cause is difficult. “It’s so easy for us to say ‘yes, it’s obesity’; ‘yes, it’s lack of exercise’; ‘yes, it’s processed food.’ But we do not have the data to point to.”
Dr. Kevin Nead, a radiation oncologist and assistant professor in the Department of Epidemiology at the MD Anderson Cancer Center, told ABC News that something different could be happening with the biology of cancer in younger patients, indicating a need for new approaches to screening and early detection.
Left entirely unaddressed by the current mainstream medical and media reporting is the potential contribution to the rising rates of brain, thyroid and salivary gland cancers of EMR (electromagnetic radiation) exposure from cellphones, Bluetooth headsets, Wi-Fi routers and 4G/5G transmission towers.
Rapid cancer onset ‘basically impossible along the known paradigm’
Dr. Harvey Risch, professor emeritus of epidemiology at the Yale School of Public Health, told The Defender, “Clinicians have been seeing very strange things, for example, 25-year-olds with colon cancer who don’t have family histories of the disease.”
He stressed that this cancer typically takes decades to develop and that its appearance in younger people is “basically impossible along the known paradigm for how colon cancer works.”
On the podcast with Makis, Dr. Peter McCullough, a prominent cardiologist and researcher, also noted the typically longer lead time for cancers to develop.
“Is what we’re seeing now — are these just individuals who have cancers at the time they take the COVID vaccines or are these brand new cancers caused by the vaccines?” he asked.
Possible mechanisms for mRNA vaccine-caused cancers
Makis hypothesized that the mRNA vaccines could be accelerating already existing cancers and are likely responsible for the recent rise in aggressive cancers.
“These lipid nanoparticles [LNPs] — one of the key features is that they don’t stay in the arm. They end up in the systemic circulation,” Makis said.
He suggested that about 75% of the injection ends up in the bloodstream within a few hours, potentially depositing “pseudouridine, modified mRNA and DNA” throughout the body. He listed the brain, bone marrow, liver, pancreas, gall bladder, spleen, testes, ovaries, liver, colon and breast milk as among the locations where these components have been found.
“We are seeing cancers where there is deposition of these vaccine particles,” he said, noting that bone marrow deposition could be causing the increased incidence of leukemia.
Risch, while cautioning that long-term data is still lacking, pointed out potential mechanisms by which vaccines might affect cancer risk.
“The spike protein is toxic,” he stated. “The LNP itself is toxic. The biological manufacturing process involving inadequate filtration of possible harmful components can be toxic.”
Both Makis and Risch discussed the “IgG4 [immunoglobin type 4] antibody shift” caused by the mRNA vaccines as a likely contributor to rapid-onset cancers.
Risch explained how this particular antibody differs from IgG1 and IgG2 responses, which work to neutralize foreign pathogens. By contrast, IgG4 creates a “tolerance response” to keep the immune system from overreacting to things like pollen and food allergens.
Makis explained how after multiple mRNA injections, the level of IgG4 antibodies markedly increases, reducing immune surveillance, thus making “cancer invisible to your immune system.”
“If you’ve got tolerance to cancer cells, it’s not going to stop the cancer cells from reproducing,” Risch said. “You don’t want that to happen.”
Risch said that no one yet knows the depth of damage to the immune surveillance mechanisms the mRNA vaccines are causing, “but there are plausible mechanisms to be looking at.”
Full vid: https://t.co/76kyipSw0T
— Sense Receptor (@SenseReceptor) August 11, 2024
Addictions
Coffee, Nicotine, and the Politics of Acceptable Addiction
From the Brownstone Institute
By
Every morning, hundreds of millions of people perform a socially approved ritual. They line up for coffee. They joke about not being functional without caffeine. They openly acknowledge dependence and even celebrate it. No one calls this addiction degenerate. It is framed as productivity, taste, wellness—sometimes even virtue.
Now imagine the same professional discreetly using a nicotine pouch before a meeting. The reaction is very different. This is treated as a vice, something vaguely shameful, associated with weakness, poor judgment, or public health risk.
From a scientific perspective, this distinction makes little sense.
Caffeine and nicotine are both mild psychoactive stimulants. Both are plant-derived alkaloids. Both increase alertness and concentration. Both produce dependence. Neither is a carcinogen. Neither causes the diseases historically associated with smoking. Yet one has become the world’s most acceptable addiction, while the other remains morally polluted even in its safest, non-combustible forms.
This divergence has almost nothing to do with biology. It has everything to do with history, class, marketing, and a failure of modern public health to distinguish molecules from mechanisms.
Two Stimulants, One Misunderstanding
Nicotine acts on nicotinic acetylcholine receptors, mimicking a neurotransmitter the brain already uses to regulate attention and learning. At low doses, it improves focus and mood. At higher doses, it causes nausea and dizziness—self-limiting effects that discourage excess. Nicotine is not carcinogenic and does not cause lung disease.
Caffeine works differently, blocking adenosine receptors that signal fatigue. The result is wakefulness and alertness. Like nicotine, caffeine indirectly affects dopamine, which is why people rely on it daily. Like nicotine, it produces tolerance and withdrawal. Headaches, fatigue, and irritability are routine among regular users who skip their morning dose.
Pharmacologically, these substances are peers.
The major difference in health outcomes does not come from the molecules themselves but from how they have been delivered.
Combustion Was the Killer
Smoking kills because burning organic material produces thousands of toxic compounds—tar, carbon monoxide, polycyclic aromatic hydrocarbons, and other carcinogens. Nicotine is present in cigarette smoke, but it is not what causes cancer or emphysema. Combustion is.
When nicotine is delivered without combustion—through patches, gum, snus, pouches, or vaping—the toxic burden drops dramatically. This is one of the most robust findings in modern tobacco research.
And yet nicotine continues to be treated as if it were the source of smoking’s harm.
This confusion has shaped decades of policy.
How Nicotine Lost Its Reputation
For centuries, nicotine was not stigmatized. Indigenous cultures across the Americas used tobacco in religious, medicinal, and diplomatic rituals. In early modern Europe, physicians prescribed it. Pipes, cigars, and snuff were associated with contemplation and leisure.
The collapse came with industrialization.
The cigarette-rolling machine of the late 19th century transformed nicotine into a mass-market product optimized for rapid pulmonary delivery. Addiction intensified, exposure multiplied, and combustion damage accumulated invisibly for decades. When epidemiology finally linked smoking to lung cancer and heart disease in the mid-20th century, the backlash was inevitable.
But the blame was assigned crudely. Nicotine—the named psychoactive component—became the symbol of the harm, even though the damage came from smoke.
Once that association formed, it hardened into dogma.
How Caffeine Escaped
Caffeine followed a very different cultural path. Coffee and tea entered global life through institutions of respectability. Coffeehouses in the Ottoman Empire and Europe became centers of commerce and debate. Tea was woven into domestic ritual, empire, and gentility.
Crucially, caffeine was never bound to a lethal delivery system. No one inhaled burning coffee leaves. There was no delayed epidemic waiting to be discovered.
As industrial capitalism expanded, caffeine became a productivity tool. Coffee breaks were institutionalized. Tea fueled factory schedules and office routines. By the 20th century, caffeine was no longer seen as a drug at all but as a necessity of modern life.
Its downsides—dependence, sleep disruption, anxiety—were normalized or joked about. In recent decades, branding completed the transformation. Coffee became lifestyle. The stimulant disappeared behind aesthetics and identity.
The Class Divide in Addiction
The difference between caffeine and nicotine is not just historical. It is social.
Caffeine use is public, aesthetic, and professionally coded. Carrying a coffee cup signals busyness, productivity, and belonging in the middle class. Nicotine use—even in clean, low-risk forms—is discreet. It is not aestheticized. It is associated with coping rather than ambition.
Addictions favored by elites are rebranded as habits or wellness tools. Addictions associated with stress, manual labor, or marginal populations are framed as moral failings. This is why caffeine is indulgence and nicotine is degeneracy, even when the physiological effects are similar.
Where Public Health Went Wrong
Public health messaging relies on simplification. “Smoking kills” was effective and true. But over time, simplification hardened into distortion.
“Smoking kills” became “Nicotine is addictive,” which slid into “Nicotine is harmful,” and eventually into claims that there is “No safe level.” Dose, delivery, and comparative risk disappeared from the conversation.
Institutions now struggle to reverse course. Admitting that nicotine is not the primary harm agent would require acknowledging decades of misleading communication. It would require distinguishing adult use from youth use. It would require nuance.
Bureaucracies are bad at nuance.
So nicotine remains frozen at its worst historical moment: the age of the cigarette.
Why This Matters
This is not an academic debate. Millions of smokers could dramatically reduce their health risks by switching to non-combustion nicotine products. Countries that have allowed this—most notably Sweden—have seen smoking rates and tobacco-related mortality collapse. Countries that stigmatize or ban these alternatives preserve cigarette dominance.
At the same time, caffeine consumption continues to rise, including among adolescents, with little moral panic. Energy drinks are aggressively marketed. Sleep disruption and anxiety are treated as lifestyle issues, not public health emergencies.
The asymmetry is revealing.
Coffee as the Model Addiction
Caffeine succeeded culturally because it aligned with power. It supported work, not resistance. It fit office life. It could be branded as refinement. It never challenged institutional authority.
Nicotine, especially when used by working-class populations, became associated with stress relief, nonconformity, and failure to comply. That symbolism persisted long after the smoke could be removed.
Addictions are not judged by chemistry. They are judged by who uses them and whether they fit prevailing moral narratives.
Coffee passed the test. Nicotine did not.
The Core Error
The central mistake is confusing a molecule with a method. Nicotine did not cause the smoking epidemic. Combustion did. Once that distinction is restored, much of modern tobacco policy looks incoherent. Low-risk behaviors are treated as moral threats, while higher-risk behaviors are tolerated because they are culturally embedded.
This is not science. It is politics dressed up as health.
A Final Thought
If we applied the standards used against nicotine to caffeine, coffee would be regulated like a controlled substance. If we applied the standards used for caffeine to nicotine, pouches and vaping would be treated as unremarkable adult choices.
The rational approach is obvious: evaluate substances based on dose, delivery, and actual harm. Stop moralizing chemistry. Stop pretending that all addictions are equal. Nicotine is not harmless. Neither is caffeine. But both are far safer than the stories told about them.
This essay only scratches the surface. The strange moral history of nicotine, caffeine, and acceptable addiction exposes a much larger problem: modern institutions have forgotten how to reason about risk.
Business
The Real Reason Canada’s Health Care System Is Failing
From the Frontier Centre for Public Policy
By Conrad Eder
Conrad Eder supports universal health care, but not Canada’s broken version. Despite massive spending, Canadians face brutal wait times. He argues it’s time to allow private options, as other countries do, without abandoning universality.
It’s not about money. It’s about the rules shaping how Canada’s health care system works
Canada’s health care system isn’t failing because it lacks funding or public support. It’s failing because governments have tied it to restrictive rules that block private medical options used in other developed countries to deliver timely care.
Canada spends close to $400 billion a year on health care, placing it among the highest-spending countries in the Organization for Economic Co-operation and Development (OECD). Yet the system continues to struggle with some of the longest waits for care, the fewest doctors per capita and among the lowest numbers of hospital beds in the OECD. This is despite decades of spending increases, including growth of 4.5 per cent in 2023 and 5.7 per cent in 2024, according to estimates from the Canadian Institute for Health Information.
Canadians are losing confidence that government spending is the solution. In fact, many don’t even think it’s making a difference.
And who could blame them? Median health care wait times reached 30 weeks in 2024, up from 27.7 weeks in 2023, which was up from 27.4 weeks in 2022, according to annual surveys by the Fraser Institute.
Nevertheless, politicians continue to tout our universal health care system as a source of national pride and, according to national surveys, 74 per cent of Canadians agree. Yet only 56 per cent are satisfied with it. This gap reveals that while Canadians value universal health care in principle, they are frustrated with it in practice.
But it isn’t universal health care that’s the problem; it’s Canada’s uniquely restrictive version of it. In most provinces, laws restrict physicians from working simultaneously in public and private systems and prohibit private insurance for medically necessary services covered by medicare, constraints that do not exist in most other universal health care systems.
The United Kingdom, France, Germany and the Netherlands all maintain universal health care systems. Like Canada, they guarantee comprehensive insurance coverage for essential health care services. Yet they achieve better access to care than Canada, with patients seeing doctors sooner and benefiting from shorter surgical wait times.
In Germany, there are both public and private hospitals. In France, universal insurance covers procedures whether patients receive them in public hospitals or private clinics. In the Netherlands, all health insurance is private, with companies competing for customers while coverage remains guaranteed. In the United Kingdom, doctors working in public hospitals are allowed to maintain private practices.
All of these countries preserved their commitment to universal health care while allowing private alternatives to expand choice, absorb demand and deliver better access to care for everyone.
Only 26 per cent of Canadians can get same-day or next-day appointments with their family doctor, compared to 54 per cent of Dutch and 47 per cent of English patients. When specialist care is needed, 61 per cent of Canadians wait more than a month, compared to 25 per cent of Germans. For elective surgery, 90 per cent of French patients undergo procedures within four months, compared to 62 per cent of Canadians.
If other nations can deliver timely access to care while preserving universal coverage, so can Canada. Two changes, inspired by our peers, would preserve universal coverage and improve access for all.
First, allow physicians to provide services to patients in both public and private settings. This flexibility incentivizes doctors to maximize the time they spend providing patient care, expanding service capacity and reducing wait times for all patients. Those in the public system benefit from increased physician availability, as private options absorb demand that would otherwise strain public resources.
Second, permit private insurance for medically necessary services. This would allow Canadians to obtain coverage for private medical services, giving patients an affordable way to access health care options that best suit their needs. Private insurance would enable Canadians to customize their health coverage, empowering patients and supporting a more responsive health care system.
These proposals may seem radical to Canadians. They are not. They are standard practice everywhere else. And across the OECD, they coexist with universal health care. They can do the same in Canada.
Alberta has taken an important first step by allowing some physicians to work simultaneously in public and private settings through its new dual-practice model. More Canadian provinces should follow Alberta’s lead and go one step further by removing legislative barriers that prohibit private health insurance for medically necessary services. Private insurance is the natural complement to dual practice, transforming private health care from an exclusive luxury into a viable option for Canadian families.
Canadians take pride in their health care system. That pride should inspire reform, not prevent it. Canada’s health care crisis is real. It’s a crisis of self-imposed constraints preventing our universal system from functioning at the level Canadians deserve.
Policymakers can, and should, preserve universal health care in this country. But maintaining it will require a willingness to learn from those who have built systems that deliver universality and timely access to care, something Canada’s current system does not.
Conrad Eder is a policy analyst at the Frontier Centre for Public Policy.
-
Alberta2 days agoThe Canadian Energy Centre’s biggest stories of 2025
-
Business2 days agoResurfaced Video Shows How Somali Scammers Used Day Care Centers To Scam State
-
Business17 hours agoDark clouds loom over Canada’s economy in 2026
-
Addictions13 hours agoCoffee, Nicotine, and the Politics of Acceptable Addiction
-
Business2 days agoOttawa Is Still Dodging The China Interference Threat
-
Business2 days agoMinneapolis day care filmed empty suddenly fills with kids
-
Business2 days agoDisclosures reveal Minnesota politician’s husband’s companies surged thousands-fold amid Somali fraud crisis
-
Business16 hours agoFederal funds FROZEN after massive fraud uncovered: Trump cuts off Minnesota child care money



